The push for COVID-19 treatments has stoked the fires on big questions about the US pharmaceutical industry, including drug pricing and conflicting data on drug effectiveness. Here's my unvarnished take.
Facebook's Mark Zuckerberg - COVID-19 usage spike won't last, but now's not the time to slam on the brakes
Facebook has three main areas of focus when it comes to tackling its COVID-19 responsibilities, says CEO Mark Zuckerberg.
Microsoft's having 'a good war' so far as COVID-19 fuels "2 years worth of digital transformation in 2 months"
Massively accelerated digital transformation priorities have kicked in as a result of the COVID-19 pandemic, reckons Microsoft CEO Satya Nadella, but can it last?
Can we draw algorithmic lessons from our immune response? How do leaders cope with anxiety? Does treating anxiety as an algorithm help us to shift behaviors? I explored these questions with startup executive Adam Goldstein.
Mandy Griffin at Calderdale and Huddersfield NHS trust on modernising healthcare informatics and technology with a patient centric approach
As panic sees Australian strip shop shelves of toilet roll CIOs and technology experts see an widespread adoption of digital health methods
Apple and Johnson & Johnson team up for Heartline Study app - a healthcare wearables breakthrough, or a questionable study?
Johnson & Johnson recently announced its Heartline Study app, which utilizes Apple Watches and iPhones, with the expected fanfare. But is this really an advancement in wearables? And, based on the official guidelines of clinical trials, does it qualify as a study?
Co-CEO Keith Block steps down, a $1.33 billion buy out of Vlocity and quarterly numbers that deliver a shock loss - a busy day at Salesforce as its 21st birthday looms.
Apple has pulled guidance and Alibaba is bracing itself for problems. How much economic damage will the Coronavirus cause before the crisis is contained?
The organisation is using AWS for scale, speed and machine learning, helping to gain insights from terabytes of data on cells and genes.
Making people healthy will help both pharmaceutical retailer Boots and the NHS says Richard Corbridge
DataStax and Deloitte have partnered to create Opioid360, a tool that uses de-identified data to help healthcare providers intervene with individuals that are at a high risk of opioid addiction.
The management consultancy firm has developed a healthcare product based on Amazon Alexa and ServiceNow that reimagines the hospital bedside call button for the digital age